what I was told is: it's unlikely that new trials will be required, they will just need to provide data to fda. It's unlikely they will
rush it to market.
Ann: Comment on research report, page-182
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.13 |
Change
-0.595(2.87%) |
Mkt cap ! $2.570B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $20.02 | $1.223M | 60.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $20.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.13 | 235 | 7 |
View Market Depth
| Last trade - 11.18am 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |